Article Details

Myovant & Pfizer's MyFembree receives nod from the FDA for endometriosis

Retrieved on: 2022-08-11 10:54:07

Tags for this article:

Click the tags to see associated articles and topics

Myovant & Pfizer's MyFembree receives nod from the FDA for endometriosis. View article details on hiswai:

Excerpt

Myovant and Pfizer's relugolix combination tablet, MyFembree, has finally received approval from the US Food and Drug Administration (FDA) for the ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up